Related Experiment Video
Updated: Oct 17, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
673
Biliary-Caval Fistula following Y90 Radioembolization
Alexander D Hall1, Sarah B White1, William S Rilling1
1Division of Vascular and Interventional Radiology, Department of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Seminars in Interventional Radiology
|October 11, 2021
Summary
Radioembolization with yttrium-90 (90Y) is generally safe, but prior biliary surgery increases risks. This review highlights a case of severe biliary complications after 90Y radioembolization.
Area of Science:
- Interventional Radiology
- Hepatobiliary Surgery
- Oncology
Background:
- Radioembolization with yttrium-90 (90Y) is a widely used treatment for liver malignancies.
- While major complications are rare, biliary complications have been noted, particularly in patients with prior biliary interventions.
- These complications include bile duct injury and hepatic abscess formation.
Purpose of the Study:
- To review a case of recurrent cholangitis, sepsis, and biliary-caval fistula following 90Y radioembolization.
- To examine current data on biliary complications after 90Y radioembolization in patients with a history of biliary surgery or interventions.
Main Methods:
- Case report review.
- Literature search for studies on 90Y radioembolization and biliary complications.
- Analysis of patient history and treatment outcomes.
Main Results:
- The reviewed case presented with severe biliary complications, including cholangitis, sepsis, and a biliary-caval fistula post-90Y radioembolization.
- Existing literature indicates an elevated risk of biliary complications in patients with prior biliary surgery or interventions.
Conclusions:
- Patients with a history of biliary surgery or interventions represent a higher-risk group for biliary complications after 90Y radioembolization.
- Careful patient selection and consideration of prior biliary interventions are crucial when planning 90Y radioembolization.
- Further research is needed to optimize management strategies for this patient subgroup.

